Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Richard Eastell, MD, FRCP

University of Sheffield
Sheffield, United Kingdom

Richard Eastell BSc (Hons), MBChB, MD (Edin), FRCP (London, Edin), FRCPI (Hon), FRCPath, FMedSci, Professor of Bone Metabolism and Director of the Mellanby Centre for Musculoskeletal Research at the University of Sheffield.

Richard qualified in medicine from Edinburgh in 1977. He trained in endocrinology in Edinburgh, Northwick Park and at the Mayo Clinic (Dr B L Riggs). He leads a research group on the pathogenesis, diagnosis and treatment of osteoporosis; of particular note is his contribution to the use of bone turnover markers and the development of treatments for osteoporosis. He was Secretary and President of the Bone Research Society as well as President of the European Calcified Tissue Society. He is an NIHR Senior Investigator (Emeritus). His work has been recognised by the Philippe Bordier Award (2012) (European Calcified Tissue Society), Frederic C Bartter Award 2014 (American Society for Bone and Mineral Research), Kohn and Linda Edwards Awards from the Royal Osteoporosis Society (2004, 2018), the Clinical Endocrinology Trust Award from the European Society for Endocrinology (2020) and the Dent Lecturer from the Bone Research Society (2021).

Presentation(s):

  • Bone Turnover Markers: Ready for Prime Time

    Sunday, November 12, 2023
    7:45 AM – 8:00 AM PT

    Disclosure(s): Alexion: Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, May 31, 2022); Biocon: Consultant (Ongoing); CL Bio: Consultant (Ongoing), Grant/Research Support (Ongoing); Immunodiagnostic Systems: Consultant (Ongoing), Grant/Research Support (Ongoing); Pharmacosmos: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Samsung Bioepis: Consultant (Ongoing); Sandoz: Consultant (Terminated, November 30, 2022); Takeda: Consultant (Terminated, August 31, 2022); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Terminated, April 14, 2023)